Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma
Farrukh T. Awan, Ran Liu, Hsin‐Hui Huang, Matthew Bye, Kwang Woo Ahn, Gabriel Krigsfeld, Anat Raz, Heather Wolfe, Mehdi Hamadani British Journal of Haematology
· Wiley
· 2026-11-10
· DOI: 10.1111/bjh.70803
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Farrukh T. Awan, Ran Liu, Hsin‐Hui Huang, Matthew Bye, Kwang Woo Ahn, Gabriel Krigsfeld et al. Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70803. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70803?af=R
Farrukh T. Awan, Ran Liu, Hsin‐Hui Huang, Matthew Bye, Kwang Woo Ahn, Gabriel Krigsfeld, Anat Raz, Heather Wolfe, & Mehdi Hamadani (2026). Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.70803
Farrukh T. Awan, et al. “Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma.” British Journal of Haematology, 2026. doi:10.1111/bjh.70803.
@article{Awan2026,
title = {Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma},
author = {Awan, Farrukh T. and Liu, Ran and Huang, Hsin‐Hui and Bye, Matthew and Ahn, Kwang Woo and Krigsfeld, Gabriel and Raz, Anat and Wolfe, Heather and Hamadani, Mehdi},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70803},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70803?af=R}
}